| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
26,081 |
24,673 |
$1.27M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,067 |
6,788 |
$456K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
6,062 |
5,958 |
$306K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
13,132 |
12,956 |
$273K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,137 |
3,137 |
$215K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,659 |
2,472 |
$199K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,721 |
2,716 |
$195K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
18,406 |
17,716 |
$164K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,981 |
1,943 |
$153K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
14,213 |
13,419 |
$145K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,516 |
3,457 |
$106K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,112 |
1,112 |
$71K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,654 |
1,592 |
$69K |
| 99173 |
|
3,716 |
3,703 |
$64K |
| 99050 |
|
4,146 |
4,076 |
$49K |
| 90461 |
|
3,558 |
3,549 |
$37K |
| 96127 |
|
3,289 |
3,266 |
$37K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,678 |
2,639 |
$30K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,752 |
2,741 |
$20K |
| 94760 |
|
3,449 |
3,276 |
$7K |
| 98966 |
|
518 |
503 |
$6K |
| 87634 |
|
57 |
57 |
$4K |
| 83655 |
|
269 |
267 |
$3K |
| 92551 |
|
257 |
257 |
$2K |
| 69210 |
|
35 |
31 |
$1K |
| 99188 |
|
38 |
38 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
60 |
53 |
$882.97 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
28 |
27 |
$633.42 |
| 99051 |
|
25 |
25 |
$397.44 |
| 83718 |
|
24 |
24 |
$166.06 |
| 81003 |
|
83 |
78 |
$164.22 |
| 99000 |
|
3,658 |
3,548 |
$121.10 |
| 94761 |
|
25 |
25 |
$100.25 |
| 82465 |
|
24 |
24 |
$88.32 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
41 |
41 |
$75.00 |
| 90686 |
|
265 |
264 |
$64.56 |
| A7015 |
Aerosol mask, used with dme nebulizer |
41 |
41 |
$15.15 |
| 96160 |
|
110 |
106 |
$12.09 |
| 96161 |
|
14 |
12 |
$7.72 |
| 90698 |
|
13 |
12 |
$0.00 |
| 90680 |
|
12 |
12 |
$0.00 |
| 90670 |
|
71 |
70 |
$0.00 |